Featured Firms
Presented by BigVoodoo
Biogen Inc. said Thursday that it has settled a lawsuit with New Jersey-based Berlex Laboratories over a patent infringement claim related to Avonex, Biogen's flagship drug used to treat multiple sclerosis. Under the settlement agreement, Cambridge, Mass.-based Biogen will pay Berlex $20 million and receive a fully paid up, royalty-free, non-exclusive license under the patents held by Berlex.
January 24, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The original national forum facilitating women-to-women exchange on leadership and current legal issues in the UK.
The premier educational and networking event for employee benefits brokers and agents.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession in Georgia.
McGovern Legal Services, LLC seeks an attorney to join our team at our North Brunswick office working with Condominium Associations, Homeown...
A well-respected regional law firm that has represented businesses in Tampa Bay for decades is seeking a commercial litigation associate to ...
An innovative surgery center headquartered in the Tampa Bay area is seeking a Counsel to handle Medical Malpractice as well as general corpo...
Lawrence Law LLC congratulates Jeralyn Lawrence, Esq. on her upcoming installation as President of the New Jersey State Bar Association
RAYNES & LAWN is Proud to Welcome Next Generation to the Firm
VAN DER VEEN HARTSHORN & LEVIN Congratulates the Attorney of the Year Finalists named by The Legal Intelligencer